Role of calcineurin signal transduction pathway in the inhibition of cardiac hypertrophy by L-arginine in vivo and in vitro

Chinese Pharmacological Bulletin

Volumn 23, Issue 9, 2007, Pages

  Jiang, Qing Song ^a   Huang, Xie Nan ^b   Zhou, Qi Xin ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b ZUNYI MEDICAL UNIVERSITY   (China)

Author keywords

Calcineurin; Cardiac hypertrophy; L arginine; Monocrotaline; Prostaglandin F 2

Indexed keywords

ARGININE; ATRIAL NATRIURETIC FACTOR; CALCINEURIN; FURA 2 ACETOXYMETHYL ESTER; MESSENGER RNA; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN F2 ALPHA; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NFAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; HEART MUSCLE CELL; HEART RIGHT VENTRICLE HYPERTROPHY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 37049025373     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Sugden P H. Signaling pathways in cardiac myocyte hypertrophy [J]. Ann Med,2001,33(9):611-22.
2. Kudoh S, Akazawa H, Takano H, et al. Stretch-modulation of second messengers: effects on cardiomyocyte ion transport[J]. Prog Biophys Mol Biol,2003,82(1-3):57-66.
3. Hogan P G, Chen L, Nardone J, Rao H. Transcriptional regulation by calcium, calcineurin, and NFAT[J]. Genes Dev,2003, 17(18):2205-32.
4. Vega R B, BasseL-Duby R, Olson E N. Control of cardiac growth and function by calcineurin signaling[J]. J Biol Chem,2003,278 (39):36981-4.
5. Zhang W. Old and new tools to dissect calcineurin's role in pressure-overload cardiac hypertrophy[J]. Cardiovasc Res,2002,53 (2):294-303.
6. De-Windt L J, Lim H W, Haq S, et al. Calcineurin promotes protein kinase C and c-jun NH2-terminal kinase activation in the heart, cross-talk between cardiac hypertrophic signaling pathways [J]. J Biol Chem,2000, 275(18):L3571-9.
7. Zhan C D. The role of nitric oxide in the prevention of myocardial hypertrophic response and its mechanisms[J]. Prog Physiol Sci, 2000,31(4):322-4.
8. Cheng T H, Shih N L, Chen S Y, et al. Nitric oxide inhibits endothelin-1-induced cardiomyocyte hypertrophy through cGMP-mediated suppression of extracellular-signal regulated kinase phosphorylation[J]. Mol Pharmacol,2005,68(4):1183-92.
9. 2+ level in the newborn rat heart cells[J]. Acta Acad Med Zunyi,2002,25(2):97-9.
10. Yang C G, Zhang X H, Pei M, Wang H L. Increased expression of 5-hydroxytryptamine transporter gene in monocrotaline-induced pulmonary hypertension in rats[J]. Chin Pharmacol Bull,2005, 21(4):404-7.
11. Chien K R, Grace A A, Hunter J J. Molecular and cellular biology of cardiac hypertrophy and failure[M]//Chien K R. Molecular basis of cardiovascular disease, Beijing; People's Medical Publishing House,2001:211-50.
12. Lai J, Jin H, Yang R, et al. Prostaglandin F2 alpha induces cardiac myocyte hypertrophy in vitro and cardiac growth in vivo[J]. Am J Physiol,1996,271(6 Pt 2):H2197-208.
13. 2α may be mediated by calcineurin in rats[J]. Acta Physiol Sin,2005,57 (6):742-8.
14. Molkentin J D. Calcineurin and beyond; cardiac hypertrophic signaling[J]. Circ Res,2000,87(9):731-8.
15. Frey N, McKinsey T A, Olson E N. Decoding calcium signals involved in cardiac growth and function[J]. Nat Med,2000,6 (11):1221-7.